These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8994455)

  • 1. Long-term outcome of panic disorder treatment. A review of the literature.
    Milrod B; Busch F
    J Nerv Ment Dis; 1996 Dec; 184(12):723-30. PubMed ID: 8994455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review.
    Bakker A; van Balkom AJ; Spinhoven P; Blaauw BM; van Dyck R
    J Nerv Ment Dis; 1998 Jul; 186(7):414-9. PubMed ID: 9680042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study.
    Nagy LM; Krystal JH; Charney DS; Merikangas KR; Woods SW
    J Clin Psychopharmacol; 1993 Feb; 13(1):16-24. PubMed ID: 8098050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.
    Albus M; Scheibe G; Scherer J
    J Affect Disord; 1995 May; 34(2):109-15. PubMed ID: 7665802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased probability of remaining in remission from panic disorder with agoraphobia after drug treatment in patients who received concurrent cognitive-behavioural therapy: a follow-up study.
    Biondi M; Picardi A
    Psychother Psychosom; 2003; 72(1):34-42. PubMed ID: 12466636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of panic disorders and agoraphobia. Psychotherapy, psychopharmacotherapy and their combination].
    Frommberger U; Angenendt J; Berger M
    Nervenarzt; 1995 Mar; 66(3):173-86. PubMed ID: 7753242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of outcome in panic disorder: a 5-year prospective follow-up study.
    Scheibe G; Albus M
    J Affect Disord; 1996 Nov; 41(2):111-6. PubMed ID: 8961038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues in the assessment of treatment response in panic disorder with special reference to fluvoxamine.
    Ninan PT
    J Clin Psychiatry; 1997; 58 Suppl 5():24-31. PubMed ID: 9184624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up.
    Albus M; Scheibe G; Scherer J
    Psychopathology; 1995; 28(5):229-34. PubMed ID: 8559945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emotion-focused psychotherapy for patients with panic disorder.
    Shear MK; Houck P; Greeno C; Masters S
    Am J Psychiatry; 2001 Dec; 158(12):1993-8. PubMed ID: 11729015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discussion of "methodological controversies in the treatment of panic disorder".
    Klein DF
    Behav Res Ther; 1996; 34(11-12):849-53; discussion 855-63. PubMed ID: 8990537
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of psychotherapy in managing panic disorder].
    Cottraux J
    Encephale; 1996 Dec; 22 Spec No 5():54-60. PubMed ID: 9138948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and Guided Mastery Therapies for Panic Disorder with Agoraphobia: 18-Year Long-Term Outcome and Predictors of Long-Term Change.
    Hoffart A; Hedley LM; Svanøe K; Sexton H
    Clin Psychol Psychother; 2016; 23(1):1-13. PubMed ID: 25452222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up study of patients with panic disorder.
    Judd FK; Burrows GD; Norman TR
    Arch Gen Psychiatry; 1991 Sep; 48(9):860-2. PubMed ID: 1929779
    [No Abstract]   [Full Text] [Related]  

  • 16. Panic disorder: a commentary.
    Tourian K; Ross D
    Md Med J; 1993 Mar; 42(3):307. PubMed ID: 8350694
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of panic disorder: summary of the NIH consensus statement.
    Md Med J; 1993 Mar; 42(3):306-7. PubMed ID: 8350693
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.
    Mavissakalian M; Perel JM
    Am J Psychiatry; 1992 Aug; 149(8):1053-7. PubMed ID: 1636805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone.
    de Beurs E; van Balkom AJ; Lange A; Koele P; van Dyck R
    Am J Psychiatry; 1995 May; 152(5):683-91. PubMed ID: 7726307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical practice guidelines.
    Schimmel P
    Australas Psychiatry; 2004 Jun; 12(2):185. PubMed ID: 15715771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.